首页> 外文期刊>The Open Biology Journal >Amyloid Oligomer Structures and Toxicity
【24h】

Amyloid Oligomer Structures and Toxicity

机译:淀粉样蛋白低聚物的结构和毒性

获取原文
       

摘要

Amyloid accumulation is commonly associated with a number of important human degenerative diseases andrecent findings indicate that soluble amyloid oligomers may represent the primary pathological species in degenerativediseases. Amyloid oligomers are structurally and morphologically diverse, raising the question on whether this diversity ispathologically significant and whether different types of oligomers may have different toxic activities. Many of theamyloids associated with neurodegenerative diseases form three immunologically distinct types of oligomers. Fibrillaroligomers are structurally related to fibrils and may represent small pieces of fibrils or fibril protofilaments. Prefibrillaroligomers are kinetic intermediates in fibril formation and annular protofibrils that resemble membrane pores. These threeclasses of oligomers share common structures and toxic activities. Focus on these common mechanisms of toxicityprovides a means of simplifying the list of primary disease mechanisms and opens the possibility of developing broadspectrum therapeutics that target several amyloid related degenerative diseases.
机译:淀粉样蛋白积累通常与许多重要的人类退化性疾病有关,并且最近的发现表明可溶性淀粉样蛋白低聚物可能代表了退化性疾病中的主要病理物种。淀粉样蛋白低聚物在结构和形态上是多种多样的,这引发了以下问题:这种多样性在病理上是否有意义,以及不同类型的寡聚物是否可能具有不同的毒性活性。与神经退行性疾病相关的许多类淀粉样蛋白形成三种免疫学上不同的寡聚体类型。原纤维寡聚体在结构上与原纤维有关,并且可能代表小片原纤维或原纤维原丝。原纤维寡聚体是原纤维形成和类似于膜孔的环形原纤维的动力学中间体。这三类低聚物具有共同的结构和毒性活性。集中于这些常见的毒性机制提供了一种简化主要疾病机制清单的方法,并为开发针对几种淀粉样变性相关疾病的广谱疗法提供了可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号